Understanding Long-Term Outcomes Following Sepsis: Implications and Challenges

Current Infectious Disease Reports

Volumn 18, Issue 11, 2016, Pages

  Shankar Hari, Manu ^a,b   Rubenfeld, Gordon D ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Causality; Epidemiology; Long term outcomes; Morbidity; Mortality; Sepsis; Survivors

Indexed keywords

CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; HEALTH STATUS; HOSPITAL READMISSION; HUMAN; INFECTION RISK; MORBIDITY; MORTALITY; MORTALITY RISK; NONHUMAN; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SURVIVOR;

EID: 84990853370     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-016-0544-7     Document Type: Review

References (89)

1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10. doi:10.1001/jama.2016.0287.
2. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock. JAMA. 2016;315(8):775. doi:10.1001/jama.2016.0289.
3. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis - Current Estimates and Limitations. Am J Respir Crit Care Med. 2015. doi:10.1164/rccm.201504-0781OC.
4. Churpek MM, Zadravecz FJ, Winslow C, Howell M, Edelson DP. Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients. Am J Respir Crit Care Med. 2015. doi:10.1164/rccm.201502-0275OC.
5. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med. 2014;42(3):625–31. doi:10.1097/CCM.0000000000000026.
6. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311(13):1308–16. doi:10.1001/jama.2014.2637.
7. Prescott HC, Langa KM, Liu V, Escobar GJ, Iwashyna TJ. Increased 1-year healthcare use in survivors of severe sepsis. Am J Respir Crit Care Med. 2014;190(1):62–9. doi:10.1164/rccm.201403-0471OC.
8. Aalen OO, Valberg M, Grotmol T, Tretli S. Understanding variation in disease risk: the elusive concept of frailty. Int J Epidemiol. 2015;44(4):1408–21. doi:10.1093/ije/dyu192.
9. Iwashyna TJ, Netzer G, Langa KM, Cigolle C. Spurious inferences about long-term outcomes: the case of severe sepsis and geriatric conditions. Am J Respir Crit Care Med. 2012;185(8):835–41. doi:10.1164/rccm.201109-1660OC.
10. Prescott HC, Dickson RP, Rogers MA, Langa KM, Iwashyna TJ. Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med. 2015;192(5):581–8. doi:10.1164/rccm.201503-0483OC.
11. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29(7 Suppl):S109–16.
12. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10.
13. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med. 2006;34(10):2576–82. doi:10.1097/01.CCM.0000239114.50519.0E.
14. Chapman SJ, Hill AV. Human genetic susceptibility to infectious disease. Nat Rev Genet. 2012;13(3):175–88. doi:10.1038/nrg3114.
15. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):1655–63. doi:10.1001/archinte.167.15.1655.
16. Yende S, Iwashyna TJ, Angus DC. Interplay between sepsis and chronic health. Trends Mol Med. 2014;20(4):234–8. doi:10.1016/j.molmed.2014.02.005.
17. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–74. doi:10.1038/nri3552.
18. Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016. doi:10.1016/s2213-2600(16)00046-1.
19. Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2014;41(1):3–11. doi:10.1097/SHK.0000000000000052.
20. Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med. 2013;187(5):509–17. doi:10.1164/rccm.201211-1983OC.
21. Lunney JR, Lynn J, Hogan C. Profiles of older medicare decedents. J Am Geriatr Soc. 2002;50(6):1108–12. doi:10.1046/j.1532-5415.2002.50268.x.
22. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387–92. doi:10.1001/jama.289.18.2387.
23. Lone NI, Walsh TS. Impact of intensive care unit organ failures on mortality during the five years after a critical illness. Am J Respir Crit Care Med. 2012;186(7):640–7. doi:10.1164/rccm.201201-0059OC.
24. Yende S, D’Angelo G, Kellum JA, Weissfeld L, Fine J, Welch RD, et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med. 2008;177(11):1242–7. doi:10.1164/rccm.200712-1777OC.
25. Shankar-Hari M, Ambler M, Mahalingasivam V, Jones A, Rowan K, Rubenfeld G. Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies. Critical Care. 2016;20(1):101. This systematic review challenges the causal relationship between sepsis and long-term mortality. Highlights methodological issues in the literatures.
26. Yende S, Linde-Zwirble W, Mayr F, Weissfeld LA, Reis S, Angus DC. Risk of cardiovascular events in survivors of severe sepsis. Am J Respir Crit Care Med. 2014;189(9):1065–74. doi:10.1164/rccm.201307-1321OC. Landmark paper on cadiovascular events in sepsis survivors and value of control arms in determining attributable risk to sepsis.
27. McConnell S, Stuart EA, Devaney B. The truncation-by-death problem: what to do in an experimental evaluation when the outcome is not always defined. Eval Rev. 2008;32(2):157–86. doi:10.1177/0193841X07309115.
28. Zhang JX, Iwashyna TJ, Christakis NA. The performance of different lookback periods and sources of information for charlson comorbidity adjustment in Medicare claims. Med Care. 1999;37(11):1128–39.
29. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399–424. doi:10.1080/00273171.2011.568786.
30. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550–60.
31. Hofler M. The Bradford Hill considerations on causality: a counterfactual perspective. Emerg Themes Epidemiol. 2005;2:11. doi:10.1186/1742-7622-2-11.
32. Prescott HC, Osterholzer JJ, Langa KM, Angus DC, Iwashyna TJ. Late mortality after sepsis: propensity matched cohort study. BMJ. 2016;353. doi:10.1136/bmj.i2375. Highlights post-acute mortality in sepsis survivors using novel statistical methods.
33. Ou SM, Chu H, Chao PW, Lee YJ, Kuo SC, Chen TJ, et al. Long-term mortality and major adverse cardiovascular events in sepsis survivors. A nationwide population-based study. Am J Respir Crit Care Med. 2016;194(2):209–17. doi:10.1164/rccm.201510-2023OC. Highlights post acute mortality in sepsis survivors.
34. Funk MJ, Westreich D, Wiesen C, Sturmer T, Brookhart MA, Davidian M. Doubly robust estimation of causal effects. Am J Epidemiol. 2011;173(7):761–7. doi:10.1093/aje/kwq439.
35. Linder A, Guh D, Boyd JH, Walley KR, Anis AH, Russell JA. Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med. 2014;42(10):2211–8. doi:10.1097/CCM.0000000000000503.
36. Prescott HC, Langa KM, Iwashyna TJ. Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions. JAMA. 2015;313(10):1055–7. doi:10.1001/jama.2015.1410.
37. Jones TK, Fuchs BD, Small DS, Halpern SD, Hanish A, Umscheid CA, et al. Post-acute care use and hospital readmission after sepsis. Ann Am Thorac Soc. 2015;12(6):904–13. doi:10.1513/AnnalsATS.201411-504OC.
38. Sun A, Netzer G, Small DS, Hanish A, Fuchs BD, Gaieski DF, et al. Association between index hospitalization and hospital readmission in sepsis survivors. Crit Care Med. 2016;44(3):478–87. doi:10.1097/CCM.0000000000001464.
39. Donnelly JP, Hohmann SF, Wang HE. Unplanned readmissions after hospitalization for severe sepsis at academic medical center-affiliated hospitals. Crit Care Med. 2015;43(9):1916–27. doi:10.1097/CCM.0000000000001147.
40. Chang DW, Tseng CH, Shapiro MF. Rehospitalizations following sepsis: common and costly. Crit Care Med. 2015;43(10):2085–93. doi:10.1097/CCM.0000000000001159.
41. Ortego A, Gaieski DF, Fuchs BD, Jones T, Halpern SD, Small DS, et al. Hospital-based acute care use in survivors of septic shock. Crit Care Med. 2015;43(4):729–37. doi:10.1097/ccm.0000000000000693.
42. Goodwin AJ, Rice DA, Simpson KN, Ford DW. Frequency, cost, and risk factors of readmissions among severe sepsis survivors. Crit Care Med. 2015;43(4):738–46. doi:10.1097/CCM.0000000000000859.
43. Zilberberg MD, Shorr AF, Micek ST, Kollef MH. Risk factors for 30-day readmission among patients with culture-positive severe sepsis and septic shock: a retrospective cohort study. J Hosp Med. 2015;10(10):678–85. doi:10.1002/jhm.2420.
44. Borzecki AM, Chen Q, Restuccia J, Mull HJ, Shwartz M, Gupta K et al. Do pneumonia readmissions flagged as potentially preventable by the 3M PPR software have more process of care problems? A cross-sectional observational study. BMJ Qual Saf. 2015. doi:10.1136/bmjqs-2014-003911.
45. Krumholz HM, Lin Z, Keenan PS, Chen J, Ross JS, Drye EE, et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA. 2013;309(6):587–93. doi:10.1001/jama.2013.333. Landmark paper on readmissions literature.
46. Wang T, Derhovanessian A, De Cruz S, Belperio JA, Deng JC, Hoo GS. Subsequent infections in survivors of sepsis: epidemiology and outcomes. J Intensive Care Med. 2014;29(2):87–95. doi:10.1177/0885066612467162.
47. Ehlenbach WJ, Hough CL, Crane PK, Haneuse SJ, Carson SS, Curtis JR, et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA. 2010;303(8):763–70. doi:10.1001/jama.2010.167.
48. Mathews SB, Arnold SE, Epperson CN. Hospitalization and cognitive decline: can the nature of the relationship be deciphered? Am J Geriatr Psychiatry. 2014;22(5):465–80. doi:10.1016/j.jagp.2012.08.012.
49. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–94. doi:10.1001/jama.2010.1553.
50. Shah FA, Pike F, Alvarez K, Angus D, Newman AB, Lopez O, et al. Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med. 2013;188(5):586–92. doi:10.1164/rccm.201212-2154OC. Important paper that addresses challenges with pre-illness cognitive decline and pneumonia.
51. Davydow DS, Hough CL, Zivin K, Langa KM, Katon WJ. Depression and risk of hospitalization for pneumonia in a cohort study of older Americans. J Psychosom Res. 2014;77(6):528–34. doi:10.1016/j.jpsychores.2014.08.002.
52. Davydow DS, Hough CL, Langa KM, Iwashyna TJ. Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans. Am J Geriatr Psychiatry. 2013;21(9):887-97. doi:10.1016/j.jagp.2013.01.017. 10.1097/JGP.0b013e31825c0aed.
53. Klein Klouwenberg PM, Zaal IJ, Spitoni C, Ong DS, van der Kooi AW, Bonten MJ, et al. The attributable mortality of delirium in critically ill patients: prospective cohort study. BMJ. 2014;349:g6652. doi:10.1136/bmj.g6652. Conceptual paper exploring acute delerium and attributable mortality.
54. Wolters AE, van Dijk D, Pasma W, Cremer OL, Looije MF, de Lange DW, et al. Long-term outcome of delirium during intensive care unit stay in survivors of critical illness: a prospective cohort study. Crit Care. 2014;18(3):R125. doi:10.1186/cc13929.
55. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513–20. doi:10.1097/CCM.0b013e3181e47be1.
56. Popp J. Delirium and cognitive decline: more than a coincidence. Curr Opin Neurol. 2013;26(6):634–9. doi:10.1097/wco.0000000000000030.
57. Tsuruta R, Oda Y. A clinical perspective of sepsis-associated delirium. J Intensive Care. 2016;4(1):1–7. doi:10.1186/s40560-016-0145-4.
58. Jones RN, Manly J, Glymour MM, Rentz DM, Jefferson AL, Stern Y. Conceptual and measurement challenges in research on cognitive reserve. J Int Neuropsychol Soc. 2011;17(4):593–601. doi:10.1017/s1355617710001748.
59. Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang CC, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313(3):264–74. doi:10.1001/jama.2014.18229.
60. Dalager-Pedersen M, Sogaard M, Schonheyder HC, Nielsen H, Thomsen RW. Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation. 2014;129(13):1387–96. doi:10.1161/circulationaha.113.006699.
61. Mejer N, Gotland N, Uhre ML, Westh H, Schonheyder HC, Petersen A, et al. Increased risk of arterial thromboembolic events after Staphylococcus aureus bacteremia: a matched cohort study. J Infect. 2015;71(2):167–78. doi:10.1016/j.jinf.2015.03.010.
62. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. 2010;38(5):1276–83. doi:10.1097/CCM.0b013e3181d8cc1d.
63. Nesseler N, Defontaine A, Launey Y, Morcet J, Malledant Y, Seguin P. Long-term mortality and quality of life after septic shock: a follow-up observational study. Intensive Care Med. 2013;39(5):881–8. doi:10.1007/s00134-013-2815-1.
64. Uthbertson BH, Elders A, Hall S, Taylor J, MacLennan G, Mackirdy F, et al. Mortality and quality of life in the five years after severe sepsis. Crit Care. 2013;17(2):R70. doi:10.1186/cc12616.
65. Yende S, Austin S, Rhodes A, Finfer S, Opal S, Thompson T et al. Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials. Crit Care Med. 2016. doi:10.1097/CCM.0000000000001658.
66. Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA. Long-term health-related quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life. Crit Care Med. 2000;28(11):3599–605.
67. Granja C, Dias C, Costa-Pereira A, Sarmento A. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness. Crit Care. 2004;8(2):R91–8. doi:10.1186/cc2818.
68. Orwelius L, Lobo C, Teixeira Pinto A, Carneiro A, Costa-Pereira A, Granja C. Sepsis patients do not differ in health-related quality of life compared with other ICU patients. Acta Anaesthesiol Scand. 2013;57(9):1201–5. doi:10.1111/aas.12164.
69. Feemster LC, Cooke CR, Rubenfeld GD, Hough CL, Ehlenbach WJ, Au DH et al. The Influence of Hospitalization or ICU Admission on Declines in Health-Related Quality of Life. Ann Am Thorac Soc. 2014. doi:10.1513/AnnalsATS.201404-172OC.
70. Esper AM, Martin GS. The impact of comorbid [corrected] conditions on critical illness. Crit Care Med. 2011;39(12):2728–35. doi:10.1097/CCM.0b013e318236f27e.
71. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–217. doi:10.1016/j.cell.2013.05.039.
72. Weiterer S, Uhle F, Lichtenstern C, Siegler BH, Bhuju S, Jarek M, et al. Sepsis induces specific changes in histone modification patterns in human monocytes. PLoS One. 2015;10(3):e0121748. doi:10.1371/journal.pone.0121748.
73. Bomsztyk K, Mar D, An D, Sharifian R, Mikula M, Gharib SA, et al. Experimental acute lung injury induces multi-organ epigenetic modifications in key angiogenic genes implicated in sepsis-associated endothelial dysfunction. Crit Care. 2015;19:225. doi:10.1186/s13054-015-0943-4.
74. Bataille A, Galichon P, Ziliotis M-J, Sadia I, Hertig A. Epigenetic changes during sepsis: on your marks! Crit Care. 2015;19:358. doi:10.1186/s13054-015-1068-5.
75. Venet F, Lukaszewicz AC, Payen D, Hotchkiss R, Monneret G. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol. 2013;25(4):477–83. doi:10.1016/j.coi.2013.05.006.
76. Singer BH, Newstead MW, Zeng X, Cooke CL, Thompson RC, Singer K, et al. Cecal ligation and puncture results in long-term central nervous system myeloid inflammation. PLoS One. 2016;11(2):e0149136. doi:10.1371/journal.pone.0149136.
77. Chavan SS, Huerta PT, Robbiati S, Valdes-Ferrer SI, Ochani M, Dancho M, et al. HMGB1 mediates cognitive impairment in sepsis survivors. Mol Med. 2012;18:930–7. doi:10.2119/molmed.2012.00195.
78. Dal-Pizzol F, Pasquali M, Quevedo J, Gelain DP, Moreira JC. Is there a role for high mobility group box 1 and the receptor for advanced glycation end products in the genesis of long-term cognitive impairment in sepsis survivors? Mol Med. 2012;18:1357-8; author reply 9. doi:10.2119/molmed.2012.00317.
79. Kaynar A, Yende S, Zhu L, Frederick D, Chambers R, Burton C, et al. Effects of intra-abdominal sepsis on atherosclerosis in mice. Crit Care. 2014;18(5):469.
80. Sweeney TE, Shidham A, Wong HR, Khatri P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med. 2015;7(287):287ra71. doi:10.1126/scitranslmed.aaa5993.
81. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581–90. doi:10.1084/jem.20111354.
82. van Vught LA, Klein Klouwenberg PM, Spitoni C, Scicluna BP, Wiewel MA, Horn J, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315(14):1469–79. doi:10.1001/jama.2016.2691.
83. Arens C, Bajwa SA, Koch C, Siegler BH, Schneck E, Hecker A, et al. Sepsis-induced long-term immune paralysis—results of a descriptive, explorative study. Crit Care. 2016;20(1):93. doi:10.1186/s13054-016-1233-5.
84. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594–605. doi:10.1001/jama.2011.1829.
85. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821.
86. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–8. doi:10.1126/science.1110591.
87. Pham TA, Lawley TD. Emerging insights on intestinal dysbiosis during bacterial infections. Curr Opin Microbiol. 2014;17:67–74. doi:10.1016/j.mib.2013.12.002.
88. Francino MP. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front Microbiol. 2015;6:1543. doi:10.3389/fmicb.2015.01543.
89. Zaborin A, Smith D, Garfield K, Quensen J, Shakhsheer B, Kade M et al. Membership and Behavior of Ultra-Low-Diversity Pathogen Communities Present in the Gut of Humans during Prolonged Critical Illness. mBio. 2014;5(5). doi:10.1128/mBio.01361-14.